Resistell Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Series B2

  • Latest Deal Amount
  • $11.4M

  • Investors
  • 15

Resistell General Information

Description

Developer of a proprietary Antibiotic Susceptibility Testing (AST) platform designed to provide rapid diagnostic results. The company's platform offers nanomotion analysis technology for phenotypic testing to detect the movement caused by living bacterial cells to determine bacterial resistance to antibiotics, enabling clients using diagnostic microbiology and microbial kinetics to improve antibiotic resistance testing with faster results, offering a new rapid AST gold standard.

Contact Information

Website
www.resistell.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Hofackerstrasse 40
  • 4132 Muttenz
  • Switzerland
+41 079
Primary Industry
Diagnostic Equipment
Vertical(s)
Nanotechnology, Digital Health, HealthTech, Life Sciences, Oncology
Corporate Office
  • Hofackerstrasse 40
  • 4132 Muttenz
  • Switzerland
+41 079

Resistell Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Resistell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC (Series B2) $11.4M Completed Product Development
12. Grant 01-Apr-2025 Completed Product Development
11. Accelerator/Incubator Completed Product Development
10. Accelerator/Incubator Completed Product Development
9. Later Stage VC (Series B) 19-Dec-2022 Completed Product Development
8. Grant 18-Mar-2020 Completed Product Development
7. Early Stage VC (Series A) 18-Dec-2019 Completed Product Development
6. Seed Round 10-Dec-2018 Completed Product Development
5. Accelerator/Incubator 10-Oct-2018 $41K $147K Completed Product Development
4. Grant 14-Jun-2018 $10.1K $106K Completed Product Development
To view Resistell’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Resistell Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a proprietary Antibiotic Susceptibility Testing (AST) platform designed to provide rapid diagnostic results
Diagnostic Equipment
Muttenz, Switzerland
19 As of 2025

Schlieren, Switzerland
 

Porto, Portugal
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Resistell Competitors (4)

One of Resistell’s 4 competitors is Clemedi, a Venture Capital-Backed company based in Schlieren, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Clemedi Venture Capital-Backed Schlieren, Switzerland
Fastinov Venture Capital-Backed Porto, Portugal
bioMerieux Corporation Durham, NC
Thermo Fisher Diagnostics Corporation Villebon-Sur-Yvette, France
To view Resistell’s complete competitors history, request access »

Resistell Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Resistell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026068687-A1 Device and apparatus for sensing and analyzing the motional activity of a particle Pending 27-Sep-2024
US-D1044129-S1 Tweezer Active 07-Sep-2022
EP-4493905-A1 Method of analysing the motional activity of particles Pending 15-Mar-2022
US-20250198902-A1 Method of analysing the motional activity of particles Pending 15-Mar-2022
WO-2023174728-A1 Method of analysing the motional activity of particles Inactive 15-Mar-2022 G01N15/10
To view Resistell’s complete patent history, request access »

Resistell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Resistell Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innosuisse Government Minority
Launchpad Venture Group Angel Group Minority
European Innovation Council Accelerator/Incubator Minority
Alpana Ventures Venture Capital Minority
TRUMPF Venture Corporate Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Ready to get started?

Request a free trial

Resistell FAQs

  • When was Resistell founded?

    Resistell was founded in 2017.

  • Where is Resistell headquartered?

    Resistell is headquartered in Muttenz, Switzerland.

  • What is the size of Resistell?

    Resistell has 19 total employees.

  • What industry is Resistell in?

    Resistell’s primary industry is Diagnostic Equipment.

  • Is Resistell a private or public company?

    Resistell is a Private company.

  • What is Resistell’s current revenue?

    The current revenue for Resistell is .

  • How much funding has Resistell raised over time?

    Resistell has raised $24.9M.

  • Who are Resistell’s investors?

    Innosuisse, Launchpad Venture Group, European Innovation Council, Alpana Ventures, and TRUMPF Venture are 5 of 15 investors who have invested in Resistell.

  • Who are Resistell’s competitors?

    Clemedi, Fastinov, bioMerieux, and Thermo Fisher Diagnostics are competitors of Resistell.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process